Abstract
The U.S. Department of Health and Human Services' Clinical Practice Guidelines have established both nicotine and nonnicotine-based pharmacotherapies as efficacious treatments for smoking cessation. Smokers attempting to quit smoking can significantly increase their chances by using one of several first-line agents, including nicotine transdermal patches, gum, nasal spray, inhalers, tablets, and the antidepressant bupropion. Those who cannot use either bupropion or nicotine replacement therapy because of contraindications or lack of effectiveness may benefit from the second-line treatment nortriptyline. This article also discusses several novel compounds for smoking cessation.
Original language | English (US) |
---|---|
Pages (from-to) | 583-589 |
Number of pages | 7 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 4 |
Issue number | 6 |
DOIs | |
State | Published - Jul 2006 |
Keywords
- Antidepressant
- Nicotine replacement treatment
- Pharmacotherapy
- Smoking cessation
ASJC Scopus subject areas
- Oncology